The release characteristics of a model protein from self-assembled succinimide-terminated poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles

Nanotechnology

Volumn 19, Issue 32, 2008, Pages

  Mercado, Angel E ^a   He, Xuezhong ^a   Xu, Weijie ^a   Jabbari, Esmaiel ^a  

^a University of South Carolina   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADABILITY; BIODEGRADATION; BODY FLUIDS; CHEMICAL REACTIONS; CHEMOTHERAPY; CIVIL AVIATION; CONDUCTIVE PLASTICS; DEGRADATION; DIALYSIS; DRUG DELIVERY; DRUG DOSAGE; EIGENVALUES AND EIGENFUNCTIONS; ENCAPSULATION; ETHYLENE; INSECTICIDES; LOCAL AREA NETWORKS; MOLECULES; MONOMERS; NANOPARTICLES; NANOSTRUCTURES; PHENOLS; POLYCONDENSATION; POLYMERS; SELF ASSEMBLY; SULFATE MINERALS; SURFACE ACTIVE AGENTS;

1-(2-PYRIDYLAZO)-2-NAPHTHOL; AMPHIPHILIC(AP); BOVINE SERUM ALBUMIN (BSA); BURST RELEASE; CONDENSATION POLYMERIZATION; END-GROUPS; ETHYLENE OXIDE (ET-O); FUMARATE; FUNCTIONALIZED NANOPARTICLES (FNP); HIGH SURFACE AREA (HSA); IN-SITU; LACTIDE (PLA); LACTIDE CO GLYCOLIDE (PLGA); MACROMERS; MODEL MOLECULES; NON-LINEAR; PROTEIN DRUGS; SELF-ASSEMBLED; SELF-ASSEMBLY; SMALL MOLECULES; SUCCINIMIDE; SUSTAINED RELEASE (SR);

NANOSTRUCTURED MATERIALS;

1 (2 PYRIDYLAZO)2 NAPHTHOL; BOVINE SERUM ALBUMIN; CARBONIC ACID; HYDROXYL GROUP; N,N' DISUCCINIMIDYL CARBONATE; NANOPARTICLE; NAPHTHOL DERIVATIVE; POLY(LACTIDE CO ETHYLENE OXIDE FUMARATE); POLY(LACTIDE CO GLYCOLIDE ETHYLENE OXIDE FUMARATE); POLY(LACTIDE FUMARATE); SUCCINIMIDE;

ARTICLE; DRUG CONJUGATION; DRUG DEGRADATION; DRUG RELEASE; DRUG STRUCTURE; ENCAPSULATION; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 47249121637     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/19/32/325609     Document Type: Article

References (63)

1. Feldman A S, McDougal W S and Harisinghani M G 2008 The potential of nanoparticle-enhanced imaging Urol. Oncol.-Semin. Original Investig. 26 65-73
2. Groneberg D A, Giersig M, Welte T and Pison U 2006 Nanoparticle-based diagnosis and therapy Curr. Drug Targets 7 643-8
3. Emerich D F and Thanos C G 2006 The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis Biomol. Eng. 23 171-84
4. Verma A and Rotello V M 2005 Surface recognition of biomacromolecules using nanoparticle receptors Chem. Commun. 303-12
5. Jin S and Ye K M 2007 Nanoparticle-mediated drug delivery and gene therapy Biotechnol. Prog. 23 32-41
6. Hosseinkhani H, Hosseinkhani M, Gabrielson N P, Pack D W, Khademhosseini A and Kobayashi H 2008 DNA nanoparticles encapsulated in 3D tissue-engineered scaffolds enhance osteogenic differentiation of mesenchymal stem cells J. Biomed. Mater. Res. A 85 47-60
7. Hosseinkhani H and Tabata Y 2006 Self assembly of DNA nanoparticles with polycations for the delivery of genetic materials into cells J. Nanosci. Nanotechnol. 6 2320-8
8. Gelperina S, Kisich K, Iseman M D and Heifets L 2005 The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis Am. J. Respir. Crit. Care Med. 172 1487-90
9. Candelaria M, Taja-Chayeb L, Arce-Salinas C, Vidal-Millan S, Serrano-Olvera A and Duenas-Gonzalez A 2005 Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives Anticancer Drugs 16 923-33
10. Kaul G and Amiji M 2004 Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model J. Drug Targeting 12 585-91
11. Owens D E and Peppas N A 2006 Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 93-102
12. Iyer A K, Khaled G, Fang J and Maeda H 2006 Exploiting the enhanced permeability and retention effect for tumor targeting Drug Discov. Today 11 812-8
13. Reddy L H 2005 Drug delivery to tumours: recent strategies J. Pharm. Pharmacol. 57 1231-42
14. Carlson C B, Mowery P, Owen R M, Dykhuizen E C and Kiessling L L 2007 Selective tumor cell targeting using low-affinity, multivalent interactions ACS Chem. Biol. 2 119-27
15. Jiang Y Y, Liu C, Hong M H, Zhu S J and Pei Y Y 2007 Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation Bioconjug. Chem. 18 41-9
16. Zhang Z P, Lee S H and Feng S S 2007 Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery Biomaterials 28 1889-99
17. Brannon-Peppas L and Blanchette J O 2004 Nanoparticle and targeted systems for cancer therapy Adv. Drug Deliv. Rev. 56 1649-59
18. Mottram P, Leong D, Crimeen-Irwin B, Gloster S, Xiang S, Meanger J, Ghildyal R, Vardaxis N and Plebanski M 2007 Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus Mol. Pharm. 4 73-84
19. Chung Y I, Ahn K M, Jeon S H, Lee S Y, Lee J H and Tae G 2007 Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex J. Control. Release 12 91-9
20. Fu Y C, Nie H, Ho M L, Wang C K and Wang C H 2008 Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2 Biotechnol. Bioeng. 99 996-1006
21. Gan Q and Wang T 2007 Chitosan nanoparticle as protein delivery carrier-Systematic examination of fabrication conditions for efficient loading and release Colloids Surf. B 59 24-34
22. Igai H, Chang S S, Gotoh M, Yamamoto Y, Yamamoto M, Tabata Y and Yokomise H 2008 Tracheal cartilage regeneration and new bone formation by slow release of bone morphogenetic protein (BMP)-2 ASAIO J. 54 104-8
23. Kumar P S, Saini T R, Chandrasekar D, Yellepeddi V K, Ramakrishna S and Diwan P V 2007 Novel approach for delivery of insulin loaded poly(lactide-co-glycolide) nanoparticles using a combination of stabilizers Drug Deliv. 14 517-23
24. Basarkar A, Devineni D, Palaniappan R and Singh J 2007 Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA Int. J. Pharm. 343 247-54
25. Tewes F, Munnier E, Antoon B, Okassa L N, Cohen-Jonathan S, Marchais H, Douziech-Eyrolles L, Souce M, Dubois P and Chourpa I 2007 Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods Eur. J. Pharm. Biopharm. 66 488-92
26. Kallinteri P, Higgins S, Hutcheon G A, St Pourcain C B and Garnett M C 2005 Novel functionalized biodegradable polymers for nanoparticle drug delivery systems Biomacromolecules 6 1885-94
27. Leo E, Brina B, Forni F and Vandelli M A 2004 In vitro evaluation of PLA nanoparticles containing a lipophilic rug in water-soluble or insoluble form Int. J. Pharm. 278 133-41
28. Jeon H J, Jeong J I, Jang M K, Park Y H and Nah J W 2000 Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics Int. J. Pharm. 207 99-108
29. Jabbari E, Florschutz A, Petersen L, Liu N, Lu L, Currier B and Yaszemski M 2004 Release characteristics of recombinant human bone morphogenic protein-2 from PLGA microspheres embedded in a poly(propylene fumarate) porous scaffold Trans. Soc. Biomater. 1 512
30. Lamprecht A, Ubrich N, Yamamoto H, Schafer U, Takeuchi H, Lehr C M, Maincent P and Kawashima Y 2001 Design of rolipram-loaded nanoparticles: comparison of two preparation methods J. Control. Release 71 297-306
31. Sahoo S K, Panyam J, Prabha S and Labhasetwar V 2002 Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake J. Control. Release 82 105-14
32. Sant S, Thommes M and Hildgen P 2008 Microporous structure and drug release kinetics of polymeric nanoparticles Langmuir 24 280-7
33. Liu Q, Cai C and Dong C 2008 Poly(L-lactide)-b-poly(ethylene oxide) copolymers with different arms: hydrophilicity, biodegradable nanoparticles, in vitro degradation, and drug-release behavior J. Biomed. Mater. Res. A at press (Apr 2 [Epub ahead of print] PMID: 18384173)
34. Lee J, Cho E and Cho K 2004 Incorporation and release behavior of hydrophobic drug in functionalized poly(D,L-lactide)-block-poly(ethylene oxide) micelles J. Control. Release 94 323-35
35. Katsikogianni G and Avgoustakis K 2006 Poly(lactide-co-glycolide)- methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties J. Nanosci. Nanotechnol. 6 3080-6
36. Avgoustakis K 2004 Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery Curr. Drug Deliv. 1 321-33
37. Westedt U, Kalinowski M, Wittmar M, Merdan T, Unger F, Fuchs J, Schaller S, Bakowsky U and Kissel T 2007 Poly(vinyl alcohol)-graft-poly(lactide-co- glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment J. Control. Release 119 41-51
38. Gao H, Wang Y N, Fan Y G and Ma J B 2007 Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system J. Biomed. Mater. Res. A 80A 111-22
39. He X, Ma J, Mercado A, Xu W and Jabbari E 2008 Cytotoxicity of paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles Pharm. Res. 25 1552-62
40. Jababri E and He X 2007 Release characteristics of novel bioresorbable in situ crosslinkable self-assembled nanoparticles CRS Abstract CS-1
41. Jabbari E and He X Z 2008 Synthesis and characterization of bioresorbable in situ crosslinkable ultra low molecular weight poly(lactide) macromer J. Mater. Sci. Mater. Med. 19 311-18
42. Jabbari E and He X 2006 Synthesis and material properties of functionalized lactide oligomers as in situ crosslinkable scaffolds for tissue regeneration Polym. Preprints 47 353-4
43. Jabbari E, He X, Valarmathi M, Sarvestani A and Xu W 2008 Material properties and bone marrow stromal cells response to in situ crosslinkable rgd-functionlized lactide-co-glycolide scaffolds J. Biomed. Mater. Res. A at press (Apr 22 [Epub ahead of print] PMID: 18431754)
44. Sarvestani A S, He X Z and Jabbari E 2007 Viscoelastic characterization and modeling of gelation kinetics of injectable in situ cross-linkable poly(lactide-co-ethylene oxide-co-fumarate) hydrogels Biomacromolecules 8 406-15
45. Sarvestani A S, Xu W J, He X Z and Jabbari E 2007 Gelation and degradation characteristics of in situ photo-crosslinked poly(L-lactid-co- ethylene oxide-co-fumarate) hydrogels Polymer 48 7113-20
46. He X Z and Jabbari E 2007 Material properties and cytocompatibility of injectable MMP degradable poly(lactide ethylene oxide fumarate) hydrogel as a carrier for marrow stromal cells Biomacromolecules 8 780-92
47. Morpurgo M, Bayer E A and Wilchek M 1999 N-hydroxysuccinimide carbonates and carbamates are useful reactive reagents for coupling ligands to lysines on proteins J. Biochem. Biophys. Methods 38 17-28
48. Xie J W and Wang C H 2005 Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel Pharm. Res. 22 2079-90
49. He X Z and Jabbari E 2006 Solid-phase synthesis of reactive peptide crosslinker by selective deprotection Protein Peptide Lett. 13 515-8
50. Silverstein R, Bassler G and Morrill T 1991 Spectrometric Identification of Organic Compounds (New York: Wiley)
51. Hobbs S K, Monsky W L, Yuan F, Roberts W G, Griffith L, Torchilin V P and Jain R K 1998 Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc. Natl Acad. Sci. USA 95 4607-12
52. Unezaki S, Maruyama K, Hosoda J, Nagae I, Koyanagi Y, Nakata M, Ishida O, Iwatsuru M and Tsuchiya S 1996 Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy Int. J. Pharm. 144 11-7
53. Brigger I, Dubernet C and Couvreur P 2002 Nanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 54 631-51
54. Gallego O and Puntes V 2006 What can nanotechnology do to fight cancer? Clin. Translational Oncol. 8 788-95
55. Nishiyama N and Kataoka K 2006 Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery Pharmacol. Ther. 112 630-48
56. Klose D, Siepmann F, Elkharraz K, Krenzlin S and Siepmann J 2006 How porosity and size affect the drug release mechanisms from PLIGA-based microparticles Int. J. Pharm. 314 198-206
57. Messaritaki A, Black S J, van der Walle C F and Rigby S P 2005 NMR and confocal microscopy studies of the mechanisms of burst drug release from PLGA microspheres J. Control. Release 108 271-81
58. Ravivarapu H B, Lee H and DeLuca P P 2000 Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load Pharm. Dev. Technol. 5 287-96
59. Siepmann J, Elkharraz K, Siepmann F and Klose D 2005 How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment Biomacromolecules 6 2312-9
60. Jabbari E, Xu W and He X 2007 Degradation characteristics of novel in situ crosslinkable poly(lactide-co-glycolide-ethylene oxide-fumarate) copolymer networks Trans. Soc. Biomater. 1 353
61. Jeon O, Kang S W, Lim H W, Chung J H and Kim B S 2006 Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel Biomaterials 27 1598-607
62. Heldin C H, Rubin K, Pietras K and Ostman A 2004 High interstitial fluid pressure-an obstacle in cancer therapy Nat. Rev. Cancer 4 806-13
63. Seeherman H, Li R, Li X and Wozney J 2003 Injectable rhBMP-2/CPM paste for closed fracture and minimally invasive orthopaedic repairs J. Musculoskelet. Neuronal Interact. 3 317-21